Literature DB >> 28912068

Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.

Carlos A Dias-Junior1, Juanjuan Chen1, Ning Cui1, Charles L Chiang1, Minglin Zhu1, Zongli Ren1, Jose S Possomato-Vieira1, Raouf A Khalil2.   

Abstract

Preeclampsia is a form of hypertension-in-pregnancy (HTN-Preg) with unclear mechanism. Generalized reduction of uterine perfusion pressure (RUPP) could be an initiating event leading to uteroplacental ischemia, angiogenic imbalance, and HTN-Preg. Additional regional differences in uteroplacental blood flow could further affect the pregnancy outcome and increase the risk of preeclampsia in twin or multiple pregnancy, but the mechanisms involved are unclear. To test the hypothesis that regional differences in angiogenic balance and matrix metalloproteinases (MMPs) underlie regional uteroplacental vascularization and feto-placental development, we compared fetal and placental growth, and placental and myoendometrial vascularization in the proximal, middle and distal regions of the uterus (in relation to the iliac bifurcation) in normal pregnant (Preg) and RUPP rats. Maternal blood pressure and plasma anti-angiogenic soluble fms-like tyrosine kinase-1 (sFlt-1)/placenta growth factor (PIGF) ratio were higher, and average placentae number, placenta weight, litter size, and pup weight were less in RUPP than Preg rats. The placenta and pup number and weight were reduced, while the number and diameter of placental and adjacent myoendometrial arteries, and MMP-2 and MMP-9 levels/activity were increased, and sFlt-1/PlGF ratio was decreased in distal vs proximal uterus of Preg rats. In RUPP rats, the placenta and pup number and weight, the number and diameter of placental and myoendometrial arteries, and MMP-2 and -9 levels/activity were decreased, and sFlt-1/PlGF ratio was increased in distal vs proximal uterus. Treatment with sFlt-1 or RUPP placenta extract decreased MMP-2 and MMP-9 in distal segments of Preg uterus, and treatment with PIGF or Preg placenta extract restored MMP levels in distal segments of RUPP uterus. Thus, in addition to the general reduction in placental and fetal growth during uteroplacental ischemia, localized angiogenic imbalance and diminished MMP-2 and MMP-9 could cause further decrease in placental and myoendometrial vascularization and placental and fetal growth in distal vs proximal uterus of HTN-Preg rats. Regional differences in uteroplacental perfusion, angiogenic balance and MMPs could be a factor in the incidence of preeclampsia in multiple pregnancy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Hypertension; Matrix metalloproteinases; Multiple pregnancy; Preeclampsia

Mesh:

Substances:

Year:  2017        PMID: 28912068      PMCID: PMC5705464          DOI: 10.1016/j.bcp.2017.09.005

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  95 in total

Review 1.  Comparative aspects of placental efficiency.

Authors:  M E Wilson; S P Ford
Journal:  Reprod Suppl       Date:  2001

2.  IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?

Authors:  Babbette Lamarca; Justin Brewer; Kedra Wallace
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-07-01

3.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

4.  Effect of inhibition of matrix metalloproteinases on endometrial decidualization and implantation in mated rats.

Authors:  M P Rechtman; J Zhang; L A Salamonsen
Journal:  J Reprod Fertil       Date:  1999-09

5.  Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.

Authors:  Jeffrey S Gilbert; Joseph Verzwyvelt; Drew Colson; Marietta Arany; S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

6.  Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats.

Authors:  Babbette LaMarca; Gerd Wallukat; Mayte Llinas; Florian Herse; Ralf Dechend; Joey P Granger
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

7.  Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery.

Authors:  Dimitrios Papazoglou; Georgios Galazios; Michael I Koukourakis; Emmanuel N Kontomanolis; Efstratios Maltezos
Journal:  Acta Obstet Gynecol Scand       Date:  2004-05       Impact factor: 3.636

8.  Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.

Authors:  Sarosh Rana; Michele R Hacker; Anna Merport Modest; Saira Salahuddin; Kee-Hak Lim; Stefan Verlohren; Frank H Perschel; S Ananth Karumanchi
Journal:  Hypertension       Date:  2012-07-02       Impact factor: 10.190

9.  Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy.

Authors:  Laura Kowalczuk; Elodie Touchard; Samy Omri; Laurent Jonet; Christophe Klein; Fatemeh Valamanes; Marianne Berdugo; Pascal Bigey; Pascale Massin; Jean-Claude Jeanny; Francine Behar-Cohen
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

Review 10.  Pre-eclampsia: pathophysiology, diagnosis, and management.

Authors:  Jennifer Uzan; Marie Carbonnel; Olivier Piconne; Roland Asmar; Jean-Marc Ayoubi
Journal:  Vasc Health Risk Manag       Date:  2011-07-19
View more
  6 in total

1.  Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.

Authors:  Zongli Ren; Ning Cui; Minglin Zhu; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-03-23       Impact factor: 4.733

2.  Placental sFlt-1 Gene Delivery in Early Primate Pregnancy Suppresses Uterine Spiral Artery Remodeling.

Authors:  Graham W Aberdeen; Jeffery S Babischkin; Jonathan R Lindner; Gerald J Pepe; Eugene D Albrecht
Journal:  Endocrinology       Date:  2022-04-01       Impact factor: 4.736

3.  Decreased uterine vascularization and uterine arterial expansive remodeling with reduced matrix metalloproteinase-2 and -9 in hypertensive pregnancy.

Authors:  Chen Lin; Hong He; Ning Cui; Zongli Ren; Minglin Zhu; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-12-13       Impact factor: 4.733

4.  TNFα blockade reverses vascular and uteroplacental matrix metalloproteinases imbalance and collagen accumulation in hypertensive pregnant rats.

Authors:  Zongli Ren; Ning Cui; Minglin Zhu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2021-10-01       Impact factor: 5.858

5.  Placental structure, function, and mitochondrial phenotype relate to fetal size in each fetal sex in mice†.

Authors:  Esteban Salazar-Petres; Daniela Pereira-Carvalho; Jorge Lopez-Tello; Amanda Nancy Sferruzzi-Perri
Journal:  Biol Reprod       Date:  2022-06-13       Impact factor: 4.161

Review 6.  Role of Gelatinases MMP-2 and MMP-9 in Healthy and Complicated Pregnancy and Their Future Potential as Preeclampsia Biomarkers.

Authors:  Asparuh Nikolov; Nikola Popovski
Journal:  Diagnostics (Basel)       Date:  2021-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.